Characterization of an activation factor released from human neutrophils after stimulation by triclinic monosodium urate crystals

Journal of Rheumatology

Volumn 33, Issue 5, 2006, Pages 928-938

  Desaulniers, Philippe ^a   Marois, Sébastien ^a   Paré, Guillaume ^a   Popa Nita, Oana ^a   Gilbert, Caroline ^a   Naccache, Paul H ^a,b  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

Chemotaxis; Gout; Human; Monosodium urate crystals; Neutrophils; Tyrosine phosphorylation

Indexed keywords

CALCIUM; CELL PROTEIN; FORMYLMETHIONYLLEUCYLPHENYLALANINE; FORMYLPEPTIDE RECEPTOR; FORMYLPEPTIDE RECEPTOR BLOCKING AGENT; INTERLEUKIN 8 ANTIBODY; LEUKOTRIENE B4; NEUTRALIZING ANTIBODY; NEUTROPHIL ACTIVATION FACTOR; PERTUSSIS TOXIN; RECEPTOR BLOCKING AGENT; THROMBOCYTE ACTIVATING FACTOR; TRYPSIN; UNCLASSIFIED DRUG; URATE;

ARTICLE; CALCIUM MOBILIZATION; CELL INTERACTION; CONTROLLED STUDY; GOUT; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE ACTIVATION; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; SUPERNATANT;

CALCIUM; CHEMOTAXIS, LEUKOCYTE; CRYSTALLIZATION; HUMANS; INTERLEUKIN-8; LEUKOTRIENE B4; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHIL ACTIVATION; NEUTROPHILS; PERTUSSIS TOXIN; PHOSPHORYLATION; PLATELET ACTIVATING FACTOR; RECEPTORS, FORMYL PEPTIDE; TYROSINE; URIC ACID;

EID: 33646444872     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Snyderman R, Uhing RJ. Chemoattractant stimulus-response coupling. In: Gallin JI, Goldstein IM, Snyderman R, editors. Inflammation: basic principles and clinical correlates. 2nd ed. New York: Raven Press; 1992:421-39.
2. Ryckman C, McColl SR, Vandal K, et al. Role of S100A8 and S100A9 in neutrophil recruitment in response to monosodium urate monohydrate crystals in the air-pouch model of acute gouty arthritis. Arthritis Rheum 2003;48:2310-20.
3. Ryckman C, Vandal K, Rouleau P, Talbot M, Tessier PA. Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion. J Immunol 2003;170:3233-42.
4. Mackarel AJ, Russell KJ, Brady CS, FitzGerald MX, O'Connor CM. Interleukin-8 and leukotriene-B(4), but not formylmethionyl leucylphenylalanine, stimulate CD18-mdependent migration of neutrophils across human pulmonary endothelial cells in vitro. Am J Respir Cell Mol Biol 2000;23:154-61.
5. Seo SM, McIntire LV, Smith CW. Effects of IL-8, Gro-alpha, and LTB(4) on the adhesive kinetics of LFA-1 and Mac-1 on human neutrophils. Am J Physiol Cell Physiol 2001;281:C1568-78.
6. Berger M, Budhu S, Lu E, et al. Different G(i)-coupled chemoattractant receptors signal qualitatively different functions in human neutrophils. J Leukoc Biol 2002;71:798-806.
7. Murray J, Ward C, O'Flaherty JT, et al. Role of leukotrienes in the regulation of human granulocyte behaviour: dissociation between agonist-induced activation and retardation of apoptosis. Br J Pharmacol 2003;139:388-98.
8. Terkeltaub R, Zachariae C, Santoro D, Martin J, Peveri P, Matsushima K. Monocyte-derived neutrophil chemotactic factor/interleukin-8 is a potential mediator of crystal-induced inflammation. Arthritis Rheum 1991;34:894-903.
9. Serhan CN, Lundberg U, Weissmann G, Samuelsson B. Formation of leukotrienes and hydroxy acids by human neutrophils and platelets exposed to monosodium urate. Prostaglandins 1984;27:563-81.
10. Serhan CN, Lundberg U, Lindgren JA, Weissmann G, Samuelsson B. Formation of leukotriene C4 by human leukocytes exposed to monosodium urate crystals. FEBS Lett 1984;167:109-12.
11. Miguelez R, Palacios I, Navarro F, et al. Anti-inflammatory effect of a PAF receptor antagonist and a new molecule with antiproteinase activity in an experimental model of acute urate crystal arthritis. J Lipid Mediat Cell Signal 1996;13:35-49.
12. Fujiwara K, Ohkawara S, Takagi K, Yoshinaga M, Matsukawa A. Involvement of CXC chemokine growth-related oncogene-alpha in monosodium urate crystal-induced arthritis in rabbits. Lab Invest 2002;82:1297-304.
13. Russell IJ, Mansen C, Kolb LM, Kolb WP. Activation of the fifth component of human complement (C5) induced by monosodium urate crystals: C5 convertase assembly on the crystal surface. Clin Immunol Immunopathol 1982;24:239-50.
14. Roberge CJ, Grassi J, De Medicis R, et al. Crystal-neutrophil interactions lead to interleukin-1 synthesis. Agents Actions 1991;34:38-41.
15. Roberge CJ, de Medicis R, Dayer JM, Rola-Pleszczynski M, Naccache PH, Poubelle PE. Crystal-induced neutrophil activation. V. Differential production of biologically active IL-1 and IL-1 receptor antagonist. J Immunol 1994;152:5485-94.
16. Poubelle PE, De Medicis R, Naccache PH. Monosodium urate and calcium pyrophosphate crystals differentially activate the excitation-response coupling sequence of human neutrophils. Biochem Biophys Res Commun 1987;149:649-57.
17. Barabe F, Gilbert C, Liao N, Bourgoin SG, Naccache PH. Crystal-induced neutrophil activation. VI. Involvement of Fc gamma RIIIB (CD16) and CD11b in response to inflammatory microcrystals. Faseb J 1998;12:209-20.
18. Gaudry M, Roberge CJ, de Medicis R, Lussier A, Poubelle PE, Naccache PH. Crystal-induced neutrophil activation. III. Inflammatory microcrystals induce a distinct pattern of tyrosine phosphorylation in human neutrophils. J Clin Invest 1993;91:1649-55.
19. Roberge CJ, Gaudry M, de Medicis R, Lussier A, Poubelle PE, Naccache PH. Crystal-induced neutrophil activation. IV. Specific inhibition of tyrosine phosphorylation by colchicine. J Clin Invest 1993;92:1722-9.
20. Jackson JK, Lauener R, Duronio V, Burt HM. The involvement of phosphatidylinositol 3-kinase in crystal induced human neutrophil activation. J Rheumatol 1997;24:341-8.
21. Naccache PH, Bourgoin S, Plante E, et al. Crystal-induced neutrophil activation. II. Evidence for the activation of a phosphatidylcholine-specific phospholipase D. Arthritis Rheum 1993;36:117-25.
22. Bomalaski JS, Baker DG, Brophy LM, Clark MA. Monosodium urate crystals stimulate phospholipase A2 enzyme activities and the synthesis of a phospholipase A2-activating protein. J Immunol 1990;145:3391-7.
23. Schumacher HR, Fishbein P, Phelps P, Tse R, Krauser R. Comparison of sodium urate and calcium pyrophosphate crystal phagocytosis by polymorphonuclear leukocytes. Effects of crystal size and other factors. Arthritis Rheum 1975;18 Suppl:783-92.
24. Bhatt AK, Spilberg I. Purification of crystal induced chemotactic factor from human neutrophils. Clin Biochem 1988;21:341-5.
25. Spilberg I, Mandell B, Wochner RD. Studies on crystal-induced chemotactic factor. I. Requirement for protein synthesis and neutral protease activity. J Lab Clin Med 1974;83:56-63.
26. Spilbert I, Gallacher A, Mehta JM, Mandell B. Urate crystal-induced chemotactic factor: isolation and partial characterization. J Clin Invest 1976;58:815-9.
27. Spilberg I, Mehta J, Simchowitz L. Induction of a chemotactic factor from human neutrophils by diverse crystals. J Lab Clin Med 1982;100:399-404.
28. Gaudry M, Caon AC, Naccache PH. Modulation of the activity and subcellular distribution of protein tyrosine kinases in human neutrophils by phorbol esters. Faseb J 1993;7:687-93.
29. Rollet-Labelle E, Gilbert C, Naccache PH. Modulation of human neutrophil responses to CD32 cross-linking by serine/threonine phosphatase inhibitors: cross-talk between serine/threonine and tyrosine phosphorylation. J Immunol 2000;164:1020-8.
30. Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985;260:3440-50.
31. Gilbert C, Levasseur S, Desaulniers P, et al. Chemotactic factor-induced recruitment and activation of Tec family kinases in human neutrophils. II. Effects of LFM-A13, a specific Btk inhibitor. J Immunol 2003;170:5235-43.
32. Rollet E, Caon AC, Roberge CJ, et al. Tyrosine phosphorylation in activated human neutrophils. Comparison of the effects of different classes of agonists and identification of the signaling pathways involved. J Immunol 1994;153:353-63.
33. McColl SR, DiPersio JF, Caon AC, Ho P, Naccache PH. Involvement of tyrosine kinases in the activation of human peripheral blood neutrophils by granulocyte-macrophage colony-stimulating factor. Blood 1991;78:1842-52.
34. L'Heureux GP, Bourgoin S, Jean N, McColl SR, Naccache PH. Diverging signal transduction pathways activated by interleukin-8 and related chemokines in human neutrophils: interleukin-8, but not NAP-2 or GRO alpha, stimulates phospholipase D activity. Blood 1995;85:522-31.
35. Torres M, Hall FL, O'Neill K. Stimulation of human neutrophils with formyl-methionyl-leucyl-phenylalanine induces tyrosine phosphorylation and activation of two distinct mitogen-activated protein-kinases. J Immunol 1993;150:1563-77.
36. Lowell CA, Berton G. Resistance to endotoxic shock and reduced neutrophil migration in mice deficient for the Src-family kinases Hck and Fgr. Proc Natl Acad Sci USA 1998;95:7580-4.
37. Lynch OT, Giembycz MA, Daniels I, Barnes PJ, Lindsay MA. Pleiotropic role of lyn kinase in leukotriene B(4)-induced eosinophil activation. Blood 2000;95:3541-7.
38. Kumar RK, Yang Z, Bilson S, Thliveris S, Cooke BE, Geczy CL. Dimeric S100A8 in human neutrophils is diminished after phagocytosis. J Leukoc Biol 2001;70:59-64.
39. Majeed M, Caveggion E, Lowell CA, Berton G. Role of Src kinases and Syk in Fc gamma receptor-mediated phagocytosis and phagosome-lysosome fusion. J Leukoc Biol 2001;70:801-11.
40. Fitzer-Attas CJ, Lowry M, Crowley MT, et al. Fc gamma receptor-mediated phagocytosis in macrophages lacking the Src family tyrosine kinases Hck, Fgr, and Lyn. J Exp Med 2000;191:669-82.
41. Gresham HD, Dale BM, Potter JW, et al. Negative regulation of phagocytosis in murine macrophages by the Src kinase family member, Fgr. J Exp Med 2000;191:515-28.
42. Cooney DS, Phee H, Jacob A, Coggeshall KM. Signal transduction by human-restricted Fc gamma RIIa involves three distinct cytoplasmic kinase families leading to phagocytosis. J Immunol 2001;167:844-54.
43. Hamada F, Aoki M. Akiyama T, Toyoshima K. Association of immunoglobulin G Fc receptor II with Src-like protein-tyrosine kinase Fgr in neutrophils. Proc Natl Acad Sci USA 1993;90:6305-9.
44. Griffiths RJ, Pettipher ER, Koch K, et al. Leukotriene B4 plays a critical role in the progression of collagen-induced arthritis. Proc Natl Acad Sci USA 1995;92:517-21.
45. Showell HJ, Pettipher ER, Cheng JB, et al. The in vitro and in vivo pharmacologic activity of the potent and selective leukotriene B4 receptor antagonist CP-105696. J Pharmacol Exp Ther 1995;273:176-84.
46. Yue TL, Gleason MM, Gu JL, Lysko PG, Hallenbeck J, Feuerstein G. Platelet-activating factor (PAF) receptor-mediated calcium mobilization and phosphoinositide turnover in neurohybrid NG108-15 cells: studies with BN50739, a new PAF antagonist. J Pharmacol Exp Ther 1991;257:374-81.
47. Seno K, Okuno T, Nishi K, et al. Pyrrolidine inhibitors of human cytosolic phospholipase A2. Part 2: synthesis of potent and crystallized 4-triphenylmethylthio derivative 'pyrrophenone'. Bioorg Med Chem Lett 2001;11:587-90.
48. Ono T, Yamada K, Chikazawa Y, et al. Characterization of a novel inhibitor of cytosolic phospholipase A2 alpha, pyrrophenone. Biochem J 2002;363:727-35.
49. Sun R, Iribarren P, Zhang N, et al. Identification of neutrophil granule protein cathepsin G as a novel chemotactic agonist for the G protein-coupled formyl peptide receptor. J Immunol 2004;173:428-36.
50. Wenzel-Seifert K, Seifert R. Cyclosporin H is a potent and selective formyl peptide receptor antagonist. Comparison with N-t-butoxycarbonyl-L- phenylalanyl-L-leucyl-L-phenylalanyl-L-leucyl-L-phenylalanine and cyclosporins A, B, C. D, and E. J Immunol 1993;150:4591-9.
51. Haribabu B, Richardson RM, Verghese MW, Barr AJ, Zhelev DV, Snyderman R. Function and regulation of chemoattractant receptors. Immunol Res 2000;22:271-9.
52. Bouchard L, Naccache PH, Poubelle PE. Promotion of neutrophil adherence to human osteoblasts by microcrystals and f-Met-Leu-Phe. Biochem Biophys Res Commun 2002;296:759-64.
53. Bouchard L, de Medicis R, Lussier A, Naccache PH, Poubelle PE. Inflammatory microcrystals alter the functional phenotype of human osteoblast-like cells in vitro: synergism with IL-1 to overexpress cyclooxygenase-2. J Immunol 2002;168:5310-7.
54. Reinhardt PH, Naccache PH, Poubelle PE, de Medicis R, Kehrli ME Jr, Kubes P. Monosodium urate crystals promote neutrophil adhesion via a CD18-independent and selectin-independent mechanism. Am J Physiol 1996;270:C31-9.
55. Terkeltaub RA, Sklar LA, Mueller H. Neutrophil activation by inflammatory microcrystals of monosodium urate monohydrate utilizes pertussis toxin-insensitive and -sensitive pathways. J Immunol 1990;144:2719-24.
56. Blackwood RA, Hartiala KT, Kwoh EE, Transue AT, Brower RC. Unidirectional heterologous receptor desensitization between both the fMLP and C5a receptor and the IL-8 receptor. J Leukoc Biol 1996;60:88-93.
57. Sabroe I, Williams TJ, Hebert CA, Collins PD. Chemoattractant cross-desensitization of the human neutrophil IL-8 receptor involves receptor internalization and differential receptor subtype regulation. J Immunol 1997;158:1361-9.
58. Gilbert C, Poubelle PE, Borgeat P, Pouliot M, Naccache PH. Crystal-induced neutrophil activation: VIII. Immediate production of prostaglandin E2 mediated by constitutive cyclooxygenase 2 in human neutrophils stimulated by urate crystals. Arthritis Rheum 2003;48:1137-48.
59. Hachicha M, Naccache PH, McColl SR. Inflammatory microcrystals differentially regulate the secretion of macrophage inflammatory protein 1 and interleukin 8 by human neutrophils; a possible mechanism of neutrophil recruitment to sites of inflammation in synovitis. J Exp Med 1995;182:2019-25.
60. Abramson S, Hoffstein ST, Weissmann G. Superoxide anion generation by human neutrophils exposed to monosodium urate. Arthritis Rheum 1982;25:174-80.
61. Ryckman C, Gilbert C, de Medicis R, Lussier A, Vandal K, Tessier PA. Monosodium urate monohydrate crystals induce the release of the proinflammatory protein S100A8/A9 from neutrophils. J Leukoc Biol 2004;76:433-40.
62. Ginsberg MH, Kozin F, Chow D, May J, Skosey JL. Adsorption of polymorphonuclear leukocyte lysosomal enzymes to monosodium urate crystals. Arthritis Rheum 1977;20:1538-42.
63. Fields TR, Abramson SB, Weissmann G, Kaplan AP, Ghebrehiwet B. Activation of the alternative pathway of complement by monosodium urate crystals. Clin Immunol Immunopathol 1983;26:249-57.
64. Chertov O, Ueda H, Xu LL, et al. Identification of human neutrophil-derived cathepsin G and azurocidin/CAP37 as chemoattractants for mononuclear cells and neutrophils. J Exp Med 1997;186:739-47.
65. Lackmann M, Cornish CJ, Simpson RJ, Moritz RL, Geczy CL. Purification and structural analysis of a murine chemotactic cytokine (CP-10) with sequence homology to S100 proteins. J Biol Chem 1992;267:7499-504.
66. Ryan J, Geczy CL. Characterization and purification of mouse macrophage procoagulant-inducing factor. J Immunol 1986;137:2864-70.
67. Yang Z, Tao T, Raftery MJ, Youssef P, Di Girolamo N, Geczy CL. Proinflammatory properties of the human S100 protein S100A12. J Leukoc Biol 2001;69:986-94.